Interventions to reduce corruption in the health sector

Cochrane Database of Systematic Reviews

Volumn 2016, Issue 8, 2016, Pages

  Gaitonde, Rakhal ^a,b   Oxman, Andrew D ^c   Okebukola, Peter O ^d   Rada, Gabriel ^e  

^a UMEÅ UNIVERSITY   (Sweden)

^b INDIAN INSTITUTE OF TECHNOLOGY MADRAS   (India)

^c NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

CORRUPTION; DRUG INDUSTRY; GERMANY; HEALTH CARE; HEALTH INSURANCE; HOSPITAL PHYSICIAN; HUMAN; INDIA; KYRGYZSTAN; LAW ENFORCEMENT; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SOCIAL PROBLEM; SOUTH KOREA; SYSTEMATIC REVIEW; UNITED STATES; CROSS-SECTIONAL STUDY; ECONOMICS; EPIDEMIOLOGY; FRAUD; HEALTH CARE COST; LEGISLATION AND JURISPRUDENCE; PREVENTION AND CONTROL; REIMBURSEMENT; SOCIAL BEHAVIOR;

CONTROLLED BEFORE-AFTER STUDIES; CROSS-SECTIONAL STUDIES; FRAUD; GERMANY; GUIDELINES AS TOPIC; HEALTH CARE SECTOR; HUMANS; INDIA; KYRGYZSTAN; LAW ENFORCEMENT; REIMBURSEMENT MECHANISMS; REPUBLIC OF KOREA; SOCIAL RESPONSIBILITY; UNITED STATES;

EID: 84982181974     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD008856.pub2     Document Type: Review

References (135)

1. Gundermann C, Meier-Hellmann A, Bauer M, Hartmann M. [Effects of a mandatory guideline that prohibit hospital doctors from accepting any form of benefits in any form from the pharmaceutical industry] [Der Einfluss einer krankenhausinternen Richtlinieauf die Einstellung von Ärzten zur pharmazeutischenIndustrie]. Deutsche Medizinische Wochenschrift 2010;135(3):67-70.
2. Huss R, Green A, Sudarshan H, Karpagam SS, Ramani KV, Tomson G, et al. Good governance and corruption in the health sector: lessons from the Karnataka experience. Health Policy and Planning 2010;26(6):471-84. [DOI: 10.1093/heapol/czq080]
3. Aleshkina J, Akkazieva B, Jakab M. Access to healthcare services and out-of-pocket payments in Kyrgyzstan: Household survey from 2001 to 2010. Policy research paper NO. 76. Health Policy Analysis Center, Bishkek, Kyrgyzstan. WHO Barcelona Office for Health Systems Strengthening. WHO Regional Office for Europe. http://metakg.org/wp-content/uploads/2014/04/4_Access-to-healthcare-services-and-out-of-pocket-payments.pdf (accessed 28 July 2016).
4. Baschieri A, Falkingham J. Formalizing informal payments: the progress of health reform in Kyrgyzstan. 2006 Central Asian Survey;25(4):441-460.
5. Falkingham J, Akkazieva B, Baschieri A. Trends in out-of-pocket payments for health care in Kyrgyzstan, 2001-2007. Health Policy and Planning 2010;25(5):427-36.
6. Kutzin J, Ibraimova AS, Meimanaliev TS, Kadyrova N, Schüth T. Addressing informal payments in Kyrgyz hospitals: a preliminary assessment. Eurohealth 2001;7(3):90-6.
7. Kang H, Hong J, Lee K, Kim S. The effects of the fraud and abuse enforcement program under the National Health Insurance program in Korea. Health Policy 2010;95(1):41-9.
8. Harrington K, Allen A, Ruchala L. Restraining Medicare abuse: the case of upcoding. Research in Healthcare Financial Management 2007;11(1):1-25.
9. Becker D, Kessler D, McClellan M. Detecting Medicare abuse. Journal of Health Economics 2005;24(1):189-210.
10. Chimonas S, Rozario NM, Rothman DJ. Show us the money: lessons in transparency from state pharmaceutical marketing disclosure laws. Health Services Research 2010;45(1):98-114.
11. Department of Health and Human Services and Department of Justice. Health Care Fraud and Abuse Control Program Annual Report for Fiscal Year 2005. http://oig.hhs.gov/reports-and-publications/hcfac/ (accessed 28 July 2016).
12. Department of Health and Human Services and Department of Justice. Health Care Fraud and Abuse Control Program Annual Report for Fiscal Year 2006. http://oig.hhs.gov/reports-and-publications/hcfac/ (accessed 28 July 2016).
13. Department of Health and Human Services and Department of Justice. Health Care Fraud and Abuse Control Program Annual Report for Fiscal Year 2007. http://oig.hhs.gov/reports-and-publications/hcfac/ (accessed 28 July 2016).
14. Department of Health and Human Services and Department of Justice. Health Care Fraud and Abuse Control Program Annual Report for Fiscal Year 2008. http://oig.hhs.gov/reports-and-publications/hcfac/ (accessed 28 July 2016).
15. Department of Health and Human Services and Department of Justice. Health Care Fraud and Abuse Control Program Annual Report for Fiscal Year 2009. http://oig.hhs.gov/reports-and-publications/hcfac/ (accessed 28 July 2016).
16. Department of Health and Human Services and Department of Justice. Health Care Fraud and Abuse Control Program Annual Report for Fiscal Year 2010. http://oig.hhs.gov/reports-and-publications/hcfac/ (accessed 28 July 2016).
17. Department of Health and Human Services and Department of Justice. Health Care Fraud and Abuse Control Program Annual Report for Fiscal Year 2011. http://oig.hhs.gov/reports-and-publications/hcfac/ (accessed 28 July 2016).
18. Department of Health and Human Services and Department of Justice. Health Care Fraud and Abuse Control Program Annual Report for Fiscal Year 2012. http://oig.hhs.gov/reports-and-publications/hcfac/ (accessed 28 July 2016).
19. Department of Health and Human Services and Department of Justice. Health Care Fraud and Abuse Control Program Annual Report for Fiscal Year 2013. http://oig.hhs.gov/reports-and-publications/hcfac/ (accessed 28 July 2016).
20. Department of Health and Human Services and Department of Justice. Health Care Fraud and Abuse Control Program Annual Report for Fiscal Year 2014. http://oig.hhs.gov/reports-and-publications/hcfac/ (accessed 28 July 2016).
21. Dietz DK, Snyder H. Internal control differences between community health centers that did or did not experience fraud. January 1 2007. http://www.thefreelibrary.com/Internal+control+differences+between+community+health+centers+that...-a0177055785 (accessed 28 July 2016).
22. Impact Initiative for Impact Evaluation (3ie). How to turn the tide on corruption? Number 17. June 2011. http://www.3ieimpact.org/media/filer_public/2012/05/07/Corruption_brief.pdf (accessed 28 July 2016).
23. Aelvoet WH, Terryn N, Windey F, Redivo M, van Sprundel M, Faes C, Cell Audit. Miscoding: a threat to the hospital care system. How to detect it?. Revue d'Epidémiologie et de Santé Publique 2009;57(3):169-77.
24. Alcázar L, Andrade R. Chapter 5: Induced demand an absenteeism in Peruvian Hospitals. In: Di Tella R, Savedoff WD editor(s). Diagnosis Corruption: Fraud in Latin America's Public Hospitals. Washington DC: Inter-American Development Bank, 2001.
25. Banerjee AV, Glennerster R, Duflo E. Putting a band-aid on a corpse: incentives for nurses in the Indian public health care system. Journal of the European Economic Association 2007;6(2-3):487-500.
26. Barber S, Bonnet F, Bekedam H. Formalizing under-the-table payments to control out-of-pocket hospital expenditures in Cambodia. Health Policy and Planning 2004;19(4):199-208.
27. Barr A, Lindelow M, Serneels P. Corruption in public service delivery: An experimental analysis. Journal of Economic Behavior & Organization 2009;72(1):225-39.
28. Berge KH, Dillon KR, Sikkink KM, Taylor TK, Lanier WL. Diversion of drugs within health care facilities, a multiple-victim crime: patterns of diversion, scope, consequences, detection, and prevention. Mayo Clinic Proceedings 2012;87(7):674-82.
29. Björkman M, Svensson J. Power to the people: evidence from a randomized field experiment of a community-based monitoring project in Uganda. http://cepr.org/active/publications/discussion_papers/dp.php?dpno=6344 (accessed 28 July 2016).
30. Björkman M, Svensson J. Power to the people: evidence from a randomized field experiment on community-based monitoring in Uganda. The Quarterly Journal of Economics 2009;124(2):735-69.
31. Blais E, Bacher JL. Situational deterrence and claim padding: results from a randomized field experiment. Journal of Experimental Criminology 2007;3(4):337-52.
32. Brown J, Mackay D, Demou E, Craig J, Frank J, Macdonald EB. The EASY (Early Access to Support for You) sickness absence service: a four-year evaluation of the impact on absenteeism. Scandinavian Journal of Work, Environment & Health 2015;41(2):204-15.
33. Casey K, Glennerster R, Miguel E. Reshaping institutions: evidence on aidimpacts using a pre-analysis plan. Working paper 17012. http://www.nber.org/papers/w17012.pdf. Cambridge, MA: Bureau of Economic Research, (accessed 28 July 2016).
34. Ching PL. Evaluating accountability in the Vaccines for Children program: protecting a federal investment. Public Health Reports 2007;122(6):718-24.
35. Cohen JC, Carikeo Montoya J. Using technology to fight corruption in pharmaceutical purchasing: lessons learned from the Chilean experience. February 20, 2001. http://citeseerx.ist.psu.edu/viewdoc/download;jsessionid=83E7D5D39DDCF377F17FB6D8CAE58AD5?doi=10.1.1.196.2132&rep=rep1&type=pdf. World Bank Institute, Washington, DC, (accessed 28 July 2016).
36. De Jaegere S, Finley S. Mapping accountability in the health sector and developing a sectoral assessment framework. UNDP mission report 2009.
37. European Commission, Directorate-General Home Affairs. Study on corruption in the healthcare sector. HOME/2011/ISEC/PR/047-A2 October 2013. http://ec.europa.eu/dgs/home-affairs/what-is-new/news/news/docs/20131219_study_on_corruption_in_the_healthcare_sector_en.pdf (accessed 28 July 2016).
38. Ferraz C, Finan F. Exposing corrupt politicians: the effects of Brazil's publicly released audits on electoral outcomes. IZA Discussion Papers, No. 2836. http://ftp.iza.org/dp2836.pdf (accessed 28 July 2016).
39. Ferraz C, Finan F. Electoral Accountability and Corruption: Evidence from the Audits of Local Governments. NBER Working Paper No. 14937. http://www.nber.org/papers/w14937.pdf (accessed 28 July 2016).
40. García-Prado A, Chawla M. The impact of hospital management reforms on absenteeism in Costa Rica. Health Policy and Planning 2006;21(2):91-100.
41. Gatti R, Gray-Molina G, Klugman J. Determinants of corruption in local health care provision: Evidence from 108 municipalities in Bolivia. http://www.siepweb.it/siep/oldDoc/wp/166.pdf. World Bank. Processed, (accessed 28 July 2016).
42. Gee J, Button M, Brooks G. The financial cost of healthcare fraud. 2011 report. http://www.cfps.hscni.net/wp-content/uploads/2012/11/PKF-Fraud_FINAL.pdf. PKF (UK) LLP and University of Portsmouth, (accessed 28 July 2016).
43. Gellar S, Salam Fall A, Kimonyo JP, Friday B. Corruption assessment of Rwandan health sector. Washington, D.C.: United States Agency for International Development, 2008.
44. Giedion U, Morales LG, Acosta OL. Chapter 6: The impact of health reforms on irregularities in Bogota hospitals. In: Di Tella R, Savedoff WD editor(s). Diagnosis Corruption: Fraud in Latin America's Public Hospitals. Washington DC: Inter-American Development Bank, 2001.
45. Gray-Molina G, Pérez de Rada E, Yañez E. Chapter 2: Does voice matter? Participation and controlling corruption in Bolivian hospitals. In: Di Tella R, Savedoff WD editor(s). Diagnosis Corruption: Fraud in Latin America's Public Hospitals. Washington DC: Inter-American Development Bank, 2001.
46. Greving JP, Denig P, de Zeeuw D, Haaijer-Ruskamp FM. Claims in advertisements for antihypertensive drugs in a Dutch medical journal. Journal of Hypertension 2007;25(3):713-22.
47. Jaén ME, Paravisini D. Chapter 3: Wages, capture and penalties in Venezuela's public hospitals. In: Di Tella R, Savedoff WD editor(s). Diagnosis Corruption: Fraud in Latin America's Public Hospitals. Washington DC: Inter-American Development Bank, 2001.
48. Klitgaard R. Introduction: Subverting corruption. Global Crime 2006;7(3-4):299-307.
49. Lee JB, Eriksen LR. The effects of a policy change on three types of absence. Journal of Nursing Administration 1990;20(7-8):37-40.
50. Leidalen E, Skarpnord R, Omre SE. Monitoring provider fraud in Norway. Eurohealth 2011;17(4):25-26.
51. Liou FM, Tang YC, Chen JY. Detecting hospital fraud and claim abuse through diabetic outpatient services. Health Care Management Science 2008;11(4):353-8.
52. Luiselli JK, DiGennaro Reed FD, Christian WP, Markowski A, Rue HC, St Amand C, et al. Effects of an informational brochure, lottery-based financial incentive, and public posting on absenteeism of direct-care human services employees. Behavior Modification 2009;33(2):175-81.
53. Markowich MM, Silver CA. How to reduce absenteeism: a comparative analysis. Hospital & Health Services Administration 1989;34(2):213-29.
54. Olken BA. Monitoring corruption: evidence from a field experiment in Indonesia. Journal of Political Economy 2007;115(2):200-49.
55. Reinikka R, Svensson J. Fighting corruption to improve schooling: evidencefrom a newspaper campaign in Uganda. Journal of the European Economic Association 2005;3(2-3):259-67.
56. Reinikka R, Svensson J. The power of information in public services: evidence from education in Uganda. Journal of Public Economics 2011;95(7-8):956-66.
57. Rivers PA, Dobalian A, Germinario FA. A review and analysis of the clinical laboratory improvement amendment of 1988: compliance plans and enforcement policy. Health Care Management Review 2005;30(2):93-102.
58. Schargrodsky E, Mera J, Weinschelbaum F. Chapter 4: Transparency and accountability in Argentina's hospitals. In: Di Tella R, Savedoff WD editor(s). Diagnosis Corruption: Fraud in Latin America's Public Hospitals. Washington DC: Inter-American Development Bank, 2001.
59. Simoens S. Analysis of drug authentication at the point of dispensing in Belgian and Greek community pharmacies. Annals of Pharmacotherapy 2009;43(10):1701-6.
60. Soeters R, Griffiths F. Improving government health services through contract management: a case from Cambodia. Health Policy and Planning 2003;18(1):74-83.
61. Stephens TA, Burroughs WA. An application of operant conditioning to absenteeism in a hospital setting. Journal of Applied Psychology 1978;63(4):518-21.
62. Stover CC. Health financing and reform in Kenya: lessons from the field. A summary and assessment of the major accomplishments of the APHIA Financing and Sustainability (AFS) Project December 1996-June 2001. http://pdf.usaid.gov/pdf_docs/Pnade338.pdf. Nairobi, Kenya, (accessed 28 July 2016).
63. United Nations Development Programme. Fighting corruption in the health sector: methods, tools and good practices. 31 October 2011. http://www.undp.org/content/undp/en/home/librarypage/democratic-governance/anti-corruption/fighting_corruptioninthehealthsector.html. United Nations Development Programme, (accessed dd Month yyyy).
64. Vardi A, Modan B, Blumstein Z, Lusky A, Schiff E, Barzilay Z. A controlled intervention in reduction of redundant hospital days. International Journal of Epidemiology 1996;25(3):604-8.
65. Vian T. Corruption in the health sector in Albania. 2003. Corruption in the health sector in Albania. USAID Corruption Reduction Project in Albania. Washington D.C.: Management Systems International, 2003.
66. Vian T. Analytical paper on corruption in the health sector. Azerbaijan anti-corruption strategy study. December 2005. http://pdf.usaid.gov/pdf_docs/Pnadp872.pdf (accessed 28 July 2016).
67. Yang WS, Hwang SY. A process-mining framework for the detection of healthcare fraud and abuse. Expert Systems with Applications 2006;31(1):56-68.
68. Di Tella R, Schargrodsky E. The role of wages and auditing during a crackdown on corruption in the city of Buenos Aires. Journal of Law and Economics 2003;46(1):269-92.
69. Dowd BE, Swenson T, Parashuram S, Coulam R, Kane R. PQRS participation, inappropriate utilization of health care services, and Medicare expenditures. Medical Care Research and Review 2016;73(1):106-23.
70. Randall ML, Rosenbaum JR, Rohrbaugh RM, Rosenheck RA. Attitudes and behaviors of psychiatry residents toward pharmaceutical representatives before and after an educational intervention. Academic Psychiatry 2005;29(1):33-9.
71. Samuel J, Frisancho A. Rights-based citizen monitoring in Peru: Evidence of impact from the field. Health and Human Rights 2015;17(2):123-34.
72. Alkhaled L, Kahale L, Nass H, Brax H, Fadlallah R, Badr K, et al. Legislative, educational, policy and other interventions targeting physicians' interaction with pharmaceutical companies: a systematic review. BMJ Open 2014;4(7):e004880.
73. Azfar O, Gurgur T. Does corruption affect health and education outcomes in the Philippines?. The IRIS Discussion Papers on Institutions and Development 2005 May;4(7):1-48.
74. Azfar O. Corruption and the delivery of health and educational services. In: Spector BI editor(s). Fighting Corruption in Developing Countries: Strategies and Analysis. Bloomfield, CT: Kumarian Press, 2005:181-212.
75. Batory A. Why do anti-corruption laws fail in Central Eastern Europe? A target compliance perspective. Regulation & Governance 2012;6(1):66-82.
76. Black's Law Dictionary. The Law Dictionary. http://thelawdictionary.org/corruption/. 8th. Eagan, Minnesota: Thompson West, (Accessed 28 July 2016).
77. Cherecheş RM, Ungureanu MI, Sandu P, Rus IA. Defining informal payments in healthcare: a systematic review. Health Policy 2013;110(2-3):105-14.
78. Chinamo O, Shumba G. Institutional Working Definition of Corruption. Anti Corruption Trust - Southern African Working Paper Series. ACT/1/2007/WPS. http://archive.kubatana.net/docs/demgg/act-sa_definition_of_corruption_080731.pdf (accessed 28 July 2016).
79. Centers for Medicare & Medicaid Services. National Health Expenditure Fact Sheet. https://www.cms.gov/research-statistics-data-and-systems/statistics-trends-and-reports/nationalhealthexpenddata/nhe-fact-sheet.html (accessed 28 July 2016).
80. Cochrane Effective Practice, Organisation of Care (EPOC). What study designs should be included in an EPOC review? EPOC Resources for review authors. http://epoc.cochrane.org/epoc-specific-resources-review-authors. Oslo: Norwegian Knowledge Centre for the Health Services, (accessed 28 July 2016).
81. Cochrane Effective Practice, Organisation of Care (EPOC). Synthesising results when it does not make sense to do a meta-analysis. EPOC Resources for review authors. http://epoc.cochrane.org/epoc-specific-resources-review-authors. Oslo: Norwegian Knowledge Centre for the Health Services, (accessed 28 July 2016).
82. Cochrane Effective Practice, Organisation of Care (EPOC). EPOC worksheets for preparing a Summary of Findings (SoF) table using GRADE. EPOC Resources for review authors. http://epoc.cochrane.org/epoc-specific-resources-review-authors. Oslo: Norwegian Knowledge Centre for the Health Services, (accessed 28 July 2016).
83. Cochrane Effective Practice, Organisation of Care (EPOC). Suggested risk of bias criteria for EPOC reviews. EPOC resources for review authors. http://epoc.cochrane.org/epoc-specific-resources-review-authors. Oslo: Norwegian Knowledge Centre for the Health Services, (accessed 28 July 2016).
84. Curran MA, Curran KE. Gambling away absenteeism. The Journal of Nursing Administration 1987;17(12):28-31.
85. Danilovik I. Corruption in an ignored sector: assessing the level of impact of bribery on patients' access to health care and suggesting possible solutions to the problem. 10th International Anti-Corruption Conference. http://www.10iacc.org/content.phtml?documents=300&art=49&c=danilovik#notes (accessed 28 July 2016).
86. Dyer O. New Report on corruption in health. Bulletin of the World Health Organization 2006;84(2):84-5.
87. Ensor T, Duran-Moreno A. Chapter 5: Corruption as a challenge to effective regulation in the health sector. In: Saltman RB, Busse R, Mossialos E (editors). Regulating entrepreneurial behaviour in European health care systems. Open University Press, Buckingham, PA, 2002. http://www.euro.who.int/__data/assets/pdf_file/0006/98430/E74487.pdf (accessed 28 July 2016).
88. Ensor T. Informal payments for health care in transition economies. Social Science & Medicine 2004;58(2):237-46.
89. Factor R, Kang M. Corruption and population health outcomes: an analysis of data from 133 countries using structural equation modelling. International Journal of Public Health 2015;60(6):633-41. [DOI: 10.1007/s00038-015-0687-6]
90. Falkingham J. Poverty, out-of-pocket payments and access to health care: evidence from Tajikistan. Social Science & Medicine 2004;58(2):247-58.
91. Federal Bureau of Investigation. Financial Crimes Report to the Public: Fiscal Years 2010-2011. https://www.fbi.gov/stats-services/publications/financial-crimes-report-2010-2011/financial-crimes-report-2010-2011#Health (accessed 28 July 2016).
92. Fretheim A, Zhang F, Ross-Degnan D, Oxman AD, Cheyne H, Foy R, et al. A reanalysis of cluster randomized trials showed interrupted time-series studies were valuable in health system evaluation. Journal of Clinical Epidemiology 2015;68(3):324-33.
93. Gaudine AP, Saks AM. Effects of an absenteeism feedback intervention on employee absence behavior. Journal of Organizational Behavior 2001;22(1):15-29.
94. Graycar A, Sidebottom A. Corruption and control: a corruption reduction approach. Journal of Financial Crime 2012;19(4):384-99.
95. Gupta S, Davoodi HR, Tiongson E. Corruption and the provision of health care and educational services. In: Abed GT, Gupta S editor(s). Governance, Corruption and Economic Performance. Washington DC: International Monetary Fund, 2002:245-72.
96. Hanf M, Van-Melle A, Fraisse F, Roger A, Carme B, Nacher M. Corruption kills: estimating the global impact of corruption on children deaths. PLoS One 2011;6(11):e26990. [DOI: 10.1371/journal.pone.0026990]
97. Hanna R, Bishop S, Nadel S, Scheffler G, Durlacher K. The effectiveness of anti-corruption policy. What has worked, what hasn't, and what we don't know-a systematic review. Technical report. http://r4d.dfid.gov.uk/PDF/Outputs/SystematicReviews/Anti_corruption_2011Hanna.pdf. London: EPPI-Centre, SocialScience Research Unit, Institute of Education, University of London, (accessed 28 July 2016).
98. Higgins JPT, Altman DG, Sterne JAC (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org. The Cochrane Collaboration.
99. Hussmann K. Addressing corruption in the health sector. Securing equitable access to health care for everyone. January 2011 No. 1. http://www.u4.no/publications/addressing-corruption-in-the-health-sector-securing-equitable-access-to-health-care-for-everyone/ (accessed dd Month yyyy).
100. Hwong AR, Qaragholi N, Carpenter D, Joffe S, Campbell EG, Soleymani Lehmann L. A systematic review of state and manufacturer physician payment disclosure websites: Implications for implementation of the Sunshine Act. The Journal of Law, Medicine & Ethics 2014;42(2):208-19.
101. Johnsøn J, Taxell N, Zaum D. Mapping evidence gaps in anti-corruption: assessing the state of the operationally relevant evidence on donors' actions and approaches to reducing corruption. October 2012 No. 7. http://r4d.dfid.gov.uk/PDF/Outputs/U4/U4Issue-2012-07-mapping-evidence-web.pdf (accessed 28 July 2016).
102. Johnsøn J, Søreide T. Methods for learning what works and why in anti-corruption. An introduction to evaluation methods for practitioners. August 2013 No. 8. http://www.u4.no/publications/methods-for-learning-what-works-and-why-in-anti-corruption-an-introduction-to-evaluation-methods-for-practitioners/. Bergen: U4 Anticorruption Resource Centre, (accessed dd Month yyyy).
103. Joudaki H, Rashidian A, Minaei-Bidgoli B, Mahmoodi M, Geraili B, Nasiri M, et al. Using data mining to detect health care fraud and abuse: a review of literature. Global Journal of Health Science 2014;7(1):194-202.
104. Killias M, Mugellini G, Isenring GL, Villettaz P. Administrative reforms in the public sector and their impact on the level of corruption: protocol for a systematic review. http://www.campbellcollaboration.org/lib/project/305/ (accessed 28 July 2016).
105. Kiwanuka SN, Nalwadda C, Pariyo GW, Ssengooba F, Rutebemberwa E. Interventions for managing absenteeism among health workers. Cochrane Database of Systematic Reviews 2014, Issue 9. [DOI: 10.1002/14651858.CD009250.pub2]
106. Lanyi A, Azfar O. Tools for Assessing Corruption & Integrity in Institutions. A Handbook. https://www.usaid.gov/sites/default/files/documents/2496/Tools%20for%20Assessing%20Corruption%20%26%20Integrity%20in%20Institutions%20PDF.pdf (accessed 28 July 2016).
107. The Lectric Law Library. The Library's Lexicon. http://www.lectlaw.com/def/c314.htm (accessed 28 July 2016).
108. Lewis M. Who is paying for health care in Eastern Europe and Central Asia?. http://web.worldbank.org/archive/website00504/WEB/PDF/WHO_IS_P.PDF (accessed 28 July 2016).
109. Lewis M. Governance and corruption in public health care systems. Working Paper Number 78. January 2006. http://www1.worldbank.org/publicsector/anticorrupt/Corruption%20WP_78.pdf. Washington DC: Center for Global Development, (accessed 28 July 2016).
110. Li H, Xu LC, Zou H. Corruption, income distribution, and growth. Economics and Politics 2000;12(2):155-81.
111. Lindelow M, Kushnarova J, Kaiser K. Measuring corruption in the health sector: what can we learn from public expenditure tracking and service delivery surveys in developing countries?. In: Transparency International, editor(s). Global Corruption Report 2006: Special Focus on Corruption and Health. London: Pluto Press, 2006.
112. Lio MC, Lee MH. Corruption costs lives: a cross-country study using an IV approach. The International Journal of Health Planning and Management 2015;31(2):175-90. [DOI: 10.1002/hpm.2305]
113. Lynch U, McGrellis S, Dutschke M, Anderson M, Arnsberger P, Macdonald G. What is the evidence that the establishment or use of community accountability mechanisms and processes improves inclusive service delivery by governments, donors and NGOs to communities?. London: Social Science Research Unit, Institute of Education, University of London, 2013.
114. Molina E, Pacheco A, Gasparini L, Cruces G, Rius A. Community monitoring to curb corruption and increase access and quality in service delivery in low- and middle-income countries: protocol for a systematic review. http://campbellcollaboration.org/lib/project/261/ (Accessed 28 July 2016).
115. Muldoon KA, Galway LP, Nakajima M, Kanters S, Hogg RS, Bendavid E, et al. Health system determinants of infant, child and maternal mortality: a cross-sectional study of UN member countries. Globalization and Health 2011;7:42. [DOI: 10.1186/1744-8603-7-42]
116. Nadpara N, Samanta S. An empirical examination of the effect of corruption on health outcomes. https://business.tcnj.edu/files/2015/07/Nadpara-Thesis-2015-revised.pdf. New Jersey: The College of New Jersey, (Accessed 28 July 2016).
117. Peisakhin LV. Field experimentation and the study of corruption. In: Rose-Ackerman S, Søreide T editor(s). International Handbook on the Economics of Corruption. Vol. 2, Cheltenham: Edward Elgar Publishing Ltd, 2011:335-55.
118. Pinzón-Flórez CE, Fernández-Niño JA, Ruiz-Rodríguez M, Idrovo ÁJ, Arredondo López AA. Determinants of performance of health systems concerning maternal and child health: a global approach. PLoS One 2015;10(3):e0120747. [DOI: 10.1371/journal.pone.0120747]
119. Rashidian A, Joudaki H, Vian T. No evidence of the effect of the interventions to combat health care fraud and abuse: a systematic review of the literature. PLoS One 2012;7(8):e41988. [DOI: 10.1371/journal.pone.0041988]
120. Rose-Ackerman S. The challenge of poor governance and corruption. Copenhagen Consensus Challenge Paper. 2004. http://www.copenhagenconsensus.com/sites/default/files/cp-corruptionfinished.pdf (accessed 28 July 2016).
121. Rose-Ackerman S, Truex R. Corruption and policy reform. Working paper prepared for the Copenhagen Consensus Project 2012. http://www.copenhagenconsensus.com/sites/default/files/workingpaper_corruption.pdf. New Haven: Yale Law School, (accessed 28 July 2016).
122. Ross JS, Lackner JE, Lurie P, Gross CP, Wolfe S, Krumholz HM. Pharmaceutical company payments to physicians: early experiences with disclosure laws in Vermont and Minnesota. JAMA 2007;297(11):1216-23.
123. Santhakumar S, Adashi EY. The Physician Payment Sunshine Act: testing the value of transparency. JAMA 2015;313(1):23-4.
124. Savedoff WD. The causes of corruption in the health sector: a focus on health care systems. Transparency International. Global Corruption Report 2006: Special Focus on Corruption and Health. London: Pluto Press, 2006.
125. Swedish International Development Cooperation Agency (SIDA). Our work against corruption. http://www.sida.se/English/how-we-work/approaches-and-methods/our-work-against-corruption/ (accessed 28 July 2016).
126. Sparrow MK. Fraud in the U.S. health care system: exposing the vulnerabilities of automated payments systems. Social Research 2008;75(4):1151-80.
127. Szende A, Culyer AJ. The inequity of informal payments for health care: the case of Hungary. Health Policy 2006;75(3):262-71.
128. Transparency International. Global Corruption Report 2006: Special Focus on Corruption and Health. London: Pluto Press, 2006.
129. U4 Anti-Corruption Resource Centre. Corruption in the Health Sector. http://www.cmi.no/publications/file/2560-corruption-in-the-health-sector.pdf (accessed dd Month yyyy).
130. United Nations Development Programme. UNDP Practice Note: Anti-Corruption. http://www.u4.no/recommended-reading/anti-corruption-practice-note/ (accessed 28 July 2016).
131. United States Agency for International Development. USAID Anticorruption Strategy. http://www.u4.no/recommended-reading/usaid-anticorruption-strategy/ (accessed dd Month yyyy).
132. Vian T. Corruption and the health sector. Sectoral Perspectives on Corruption. Vol. 1, Washington D.C.: USAID, 2002:1-7.
133. Vian T. Review of corruption in the health sector:theory, methods and interventions. Health Policy and Planning 2008;23(2):83-94.
134. World Bank. Helping countries combat corruption, the role of the World Bank. September 1997. http://www1.worldbank.org/publicsector/anticorrupt/corruptn/corrptn.pdf (accessed 28 July 2016).
135. Gaitonde R, Bjørndal A, Oxman AD, Okebukola PO, Ongolo-Zogo P. Interventions to reduce corruption in the health sector. Cochrane Database of Systematic Reviews 2010, Issue 11. [DOI: 10.1002/14651858.CD008856]